Home » News
Lyophilized Stem Cell Conditioned Media as an Active Ingredient for the Cosmetic Industry Tested and Validated in Cosmetic Products for a Decade

 November 30, 2015 06:22 PM Eastern Standard Time

TORRANCE, Calif. () Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for the development of stem cell technologies for regenerative medicine, today announced that they have adult adipose stem cell derived conditioned media (AASCDCM) containing stem cells growth components for the skin care regenerative products. These stem cell derived conditioned media have been utilized in skin care products for a decade. The lyophilized adult adipose stem cell derived conditioned media is approximately 90% as an active ingredient in regenerative skin care topical products. Celprogen manufactures these lyophilized adult adipose and mesenchymal derived stem cell conditioned media which is serum free and devoid of all animal components in mg to Kg batch sizes for the cosmetic industry. This product is also available in the liquid format with 2000L to 10,000L batch sizes. The advantage of lyophilized material is that its shelf life is 2 years at 2-8°C, whereas the liquid product has 1 year at -20°C; the other advantage of the lyophilized product is the ease of shipment to any part of the world.

 

The present lyophilized AASCDCM invention relates to culturing stem cells in animal free conditions and has been developed and optimized by Celprogen utilizing single use bioreactor technology. The cosmetic industry has benefited from this technology for their regenerative skin care product lines. The topical application of these skin care products utilizing Celprogen’s Stem Cell Derived Conditioned Media have been in the market for 10 plus years.

About Celprogen Inc.

Celprogen Inc. is a global Stem Cell Research & Therapeutics company which is developing a proprietary portfolio of unique therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in Torrance, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell, Cancer Stem Cell and Primary Cell Culture products to serve our global community. Additional information about Celprogen is available at http://www.celprogen.com.

 

Contacts

Celprogen Inc.
Jay Sharma, 310-575-7759
info@celprogen.com
www.celprogen.com

Back to News Listing